Thinking beyond
the binary

Meet the biomodal leadership team

Scientist using a pipette

We work to expand the dimensions of genetic discovery

Our culture is diverse, inquisitive, collaborative, and nimble, aiming to defy existing paradigms.

Executive leadership team

Chief Executive Officer
Chief Financial Officer
Vice President, Global Marketing & Product Management
Senior Vice President, Research & Development
Head of Global Operations
Head of Intellectual Property
Vice President, Computational Technologies
Global Head of Business Development and Customer Solutions

Board of directors

Chair of the Board
Chief Executive Officer
General Partner, GV

Scientific advisory board

Head of the Epigenetics Programme, Babraham Institute
Head of the Division of Signalling and Gene Expression, La Jolla Institute
Group Leader of the Cancer Epigenetics Laboratory, Peter MacCallum Cancer Centre
Director of the Li Ka Shing Institute of Health Sciences

Board observers

Founder & Board Observer
Board Observer
Managing Partner, Ahren Innovation Capital
Managing Partner, New Science Ventures
Board Observer
Board Observer

Our investors

New Science Ventures

Our science

Gain greater insight into genetics and disease. biomodal’s multiomics technologies provide both genetic and epigenetic information using your existing sequencing and computing platforms.

Scientist using a pipette
Cambridge Epigenetix is now biomodal